Shares of Pfizer rose 2.8% to $29.14 in premarket trading.
- Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year.
The drugmaker did not lay out an exact timeline for development of the drug. It plans to evaluate multiple doses of the reformulated drug in the second half of this year before advancing it into clinical trials. JP Morgan analyst Chris Schott said in a research note that Eli Lilly's experimental weight-loss pill has a significant time-to-market advantage over Pfizer's and he was still concerned about side-effects from the drug.
پاکستان تازہ ترین خبریں, پاکستان عنوانات
Similar News:آپ اس سے ملتی جلتی خبریں بھی پڑھ سکتے ہیں جو ہم نے دوسرے خبروں کے ذرائع سے جمع کی ہیں۔
What other health conditions are weight-loss drugs being tested for?Alzheimer's and neurological disorders among those diseases which are being focused upon
مزید پڑھ »
Child obesity remains a challenge as weight-loss options are hard to come byLeading medical groups recommend intensive behavioural counselling
مزید پڑھ »
Novo Nordisk, Lilly must cut US weight-loss drugs prices: BidenWrites a joint opinion piece with Senator Bernie Sanders for USA Today
مزید پڑھ »
Vidya Balan's unbelievable weight loss sends shockwaves across internetUnveil Vidya Balan's remarkable weight loss journey and the health regime that led to her stunning transformation, inspiring fans...
مزید پڑھ »
Finnish Parliament moves forward with law to block migrants at Russia borderAn influential committee of legislators said on Tuesday that Finland’s parliament could approve a government proposal to temporarily
مزید پڑھ »
PM Shehbaz invites Opp to sit with govt to resolve issuesPM Shehbaz once again invited Opposition to sit with govt to sort out the issues, take the country forward on the path of development
مزید پڑھ »